Eli Lilly’s new GLP-1 weight-loss pill, Foundayo, is now available through Amazon-connected channels, including One Medical kiosks and same-day delivery via Amazon Pharmacy. The pill, approved by the FDA, is sold through LillyDirect and fulfilled by Amazon Pharmacy, allowing patients to receive prescriptions after speaking with a healthcare professional and, in some cases, the same day.
Unlike injectable GLP-1 drugs that need refrigeration, Foundayo is a pill and can be stored at room temperature, enabling Amazon to stock it in kiosks. Tanvi Patel, a vice president at Amazon Pharmacy, said that because the pill does not require cold storage, it can be kept safely in kiosks for dispensing. Amazon’s kiosks have also been dispensing Novo Nordisk’s oral Wegovy since January.
Amazon launched kiosks linked to One Medical locations in 2025; there are currently five kiosks in California. The kiosks aim to reduce barriers to accessing medications and limit delivery fees. One Medical is Amazon’s primary and urgent care service; a one-year subscription costs $199, or $99 for Prime members. People without a One Medical membership can still book appointments and use the kiosks. Amazon plans to expand the kiosk model beyond California in 2026 and is in discussions with external health systems to place more machines, according to Hannah McClellan Richards, a vice president at Amazon Pharmacy.
Patients can also get Foundayo through Lilly’s prescribing partners, including WW International, and some users may be eligible for same-day delivery directly through Amazon. Amazon indicated a goal to expand same-day delivery to 4,500 locations by year’s end. WW and GoodRx announced they will offer Foundayo at self-pay prices starting at $149 per month for the lowest dose.
Coverage and out-of-pocket costs vary. Foundayo may cost as little as $25 per month for people with commercial insurance. Medicare Part D beneficiaries may be able to obtain Foundayo for about $50 per month beginning in July. Lilly has resources for coverage and savings options.
Clinicians note the value of adding another treatment option for obesity. Zhaoping Li, MD, chief of Clinical Nutrition at UCLA Health, said new tools are welcome. Mir Ali, MD, a bariatric surgeon and medical director at MemorialCare Surgical Weight Loss Center, noted that some patients prefer weekly injections while others favor a daily pill; an advantage of the pill is it does not require refrigeration, which is convenient for travel.
Foundayo’s dosing begins at 0.8 mg, increasing to 2.5 mg after 30 days and 5.5 mg after another 30 days. Doses may be raised to 9 mg, 14.5 mg, or 17.2 mg with at least 30 days between increases, depending on individual response and tolerance.
If you think you may qualify for Foundayo or another GLP-1 medication, consult your healthcare provider for guidance on eligibility, dosing, and coverage.
